Indication
Adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.

Medicine details

Medicine name:
perampanel (Fycompa)
SMC ID:
SMC2172
Pharmaceutical company
Eisai Ltd
BNF chapter
Endocrine system
Submission type
Abbreviated
Status
Publication due date:
12 August 2019
SMC meeting date:
02 July 2019
Patient group submission deadline:
TBC